Ftse Mib
38.450,75
-0,53%
DAX
22.557,47
0,28%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
91.347,90
-3,08%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Treace Medical Concepts Inc (TMCI) Treace Medical Concepts Inc (TMCI) Notizie

Treace Medical Concepts Inc

TMCI
8,94
0,00 (0,00%)
03 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202522:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202522:05GLOBETreace Medical Concepts Reports Fourth Quarter and Full-Year..
27/2/202522:04EDGAR2Form 8-K - Current report
06/2/202522:15GLOBETreace to Report Fourth Quarter and Full-Year 2024 Financial..
30/1/202514:00GLOBETreace Announces First Surgical Cases Utilizing the..
25/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202514:05EDGAR2Form 8-K - Current report
13/1/202514:00GLOBETreace Announces Preliminary, Unaudited Fourth Quarter and..
02/1/202522:15GLOBETreace to Present at 43rd Annual J.P. Morgan Healthcare..
30/12/202414:15GLOBETreace Expands Reach into High-Volume Osteotomy Market with..
16/12/202414:30GLOBETreace Announces First Surgical Cases Utilizing the..
05/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/12/202422:15GLOBETreace Announces First Cases Utilizing RedPoint™..
02/12/202422:15GLOBETreace Appoints Guy Guglielmino as Chief Commercial Officer
18/11/202422:46GLOBETreace Announces Participation at Stifel 2024 Healthcare..
14/11/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202422:06EDGAR2Form 8-K - Current report
05/11/202422:05GLOBETreace Medical Concepts Reports Third Quarter 2024 Financial..
04/11/202423:29GLOBETreace Announces Participation in the UBS Global Healthcare..
04/11/202414:00GLOBETreace Comments on CMS’ 2025 Final Rule for Hospital..
04/11/202413:00GLOBETreace Enters High Volume Osteotomy Market with Nanoplasty™..
22/10/202422:30GLOBETreace to Report Third Quarter 2024 Financial Results on..
15/10/202422:25EDGAR2Form 8-K - Current report
14/10/202415:45GLOBETreace Files Patent Infringement and Unfair Competition..
03/10/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202414:00GLOBETreace Highlights New Product Innovations and Updated..
22/8/202422:15GLOBETreace Announces Participation in the Morgan Stanley 22nd..
15/8/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:05GLOBETreace Medical Concepts Reports Second Quarter 2024..
18/7/202422:30GLOBETreace to Report Second Quarter 2024 Financial Results on..
11/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202413:00GLOBETreace to Present at Truist Securities MedTech Conference
22/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 8,94

La tua Cronologia

NASDAQ
TMCI
Treace Medical Concepts
AQSE
VOF.GB
VinaCapital Vietnam Oppo...
BIT
UI108C
Unicredit Bank
TSX
OSP.PR.A
Brompton Oil Split
USOTC
ABVG
Affinity Beverage (CE)
TG
UU2
Blackrock
TG
ZPDU
State Street Global Advi...
BIT
P1RLO3
BNP Paribas Issuance
BIT
P1PUT7
BNP Paribas Issuance
BIT
P1J7R1
BNP Paribas Issuance
NASDAQ
LIDRW
AEye
COIN
MBNNUST
Mobilian
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci